These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of the organ microenvironment in brain metastasis. Fidler IJ Semin Cancer Biol; 2011 Apr; 21(2):107-12. PubMed ID: 21167939 [TBL] [Abstract][Full Text] [Related]
3. Brain metastases of gastro-oesophageal cancer: evaluation of molecules with relevance for targeted therapies. Preusser M; Berghoff AS; Ilhan-Mutlu A; Dinhof C; Magerle M; Marosi C; Hejna M; Capper D; VON Deimling A; Schoppmann SF; Birner P Anticancer Res; 2013 Mar; 33(3):1065-71. PubMed ID: 23482783 [TBL] [Abstract][Full Text] [Related]
4. The roles of chemokine CXCL12 in embryonic and brain tumor angiogenesis. Li M; Ransohoff RM Semin Cancer Biol; 2009 Apr; 19(2):111-5. PubMed ID: 19038344 [TBL] [Abstract][Full Text] [Related]
5. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy. Abdollahi A; Folkman J Drug Resist Updat; 2010; 13(1-2):16-28. PubMed ID: 20061178 [TBL] [Abstract][Full Text] [Related]
6. The molecular pathobiology of metastasis to the brain: a review. Beasley KD; Toms SA Neurosurg Clin N Am; 2011 Jan; 22(1):7-14, v. PubMed ID: 21109144 [TBL] [Abstract][Full Text] [Related]
7. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway. Gollob JA; Wilhelm S; Carter C; Kelley SL Semin Oncol; 2006 Aug; 33(4):392-406. PubMed ID: 16890795 [TBL] [Abstract][Full Text] [Related]
8. Brain metastasis: opportunity for drug development? Preusser M; Berghoff AS; Schadendorf D; Lin NU; Stupp R Curr Opin Neurol; 2012 Dec; 25(6):786-94. PubMed ID: 23108247 [TBL] [Abstract][Full Text] [Related]
9. Biology of brain metastases and novel targeted therapies: time to translate the research. Fokas E; Steinbach JP; Rödel C Biochim Biophys Acta; 2013 Jan; 1835(1):61-75. PubMed ID: 23142311 [TBL] [Abstract][Full Text] [Related]
10. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas. Wong ML; Prawira A; Kaye AH; Hovens CM J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134 [TBL] [Abstract][Full Text] [Related]
11. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor. Shibuya M FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071 [TBL] [Abstract][Full Text] [Related]
12. Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactions. Anderson KC Exp Hematol; 2007 Apr; 35(4 Suppl 1):155-62. PubMed ID: 17379101 [TBL] [Abstract][Full Text] [Related]
13. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. Chung LW; Baseman A; Assikis V; Zhau HE J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017 [TBL] [Abstract][Full Text] [Related]
14. Targeted therapy for brain metastases. Davies MA Adv Pharmacol; 2012; 65():109-42. PubMed ID: 22959025 [TBL] [Abstract][Full Text] [Related]
15. The Biology of Brain Metastasis: Challenges for Therapy. Fidler IJ Cancer J; 2015; 21(4):284-93. PubMed ID: 26222080 [TBL] [Abstract][Full Text] [Related]
16. [Novel angiogenesis inhibitors for molecular target therapy of cancer]. Osada H; Kakeya H Nihon Rinsho; 2004 Jul; 62(7):1257-63. PubMed ID: 15283141 [TBL] [Abstract][Full Text] [Related]
17. Treatment of brain metastases from lung cancer: chemotherapy. Schuette W Lung Cancer; 2004 Aug; 45 Suppl 2():S253-7. PubMed ID: 15552807 [TBL] [Abstract][Full Text] [Related]
18. Small-molecule and antibody approaches to molecular chemotherapy of primary brain tumors. Newton HB Curr Opin Investig Drugs; 2007 Dec; 8(12):1009-21. PubMed ID: 18058572 [TBL] [Abstract][Full Text] [Related]
19. The use of systemic therapies for the treatment of brain metastases in metastatic melanoma: opportunities and unanswered questions. Murrell J; Board R Cancer Treat Rev; 2013 Dec; 39(8):833-8. PubMed ID: 23845462 [TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis. Küsters B; Leenders WP; Wesseling P; Smits D; Verrijp K; Ruiter DJ; Peters JP; van Der Kogel AJ; de Waal RM Cancer Res; 2002 Jan; 62(2):341-5. PubMed ID: 11809675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]